施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BMY 施贵宝

未开盘 05-08 16:00:00 EDT

46.88

-0.74

-1.55%

盘后46.89

+0.01+0.02%

19:59 EDT

最高47.40	最低46.52	成交量2,340万
今开47.00	昨收47.62	日振幅1.84%
总市值954.05亿	流通市值952.20亿	总股本20.35亿
成交额11.00亿	换手率1.15%	流通股本20.31亿
市净率5.49	ROE31.99%	每股收益2.67
52周最高63.33	52周最低39.35	市盈率17.55
股息2.44	股息收益率0.05	ROA7.24%

北京优虎网络科技有限公司

{"stockData":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"施贵宝","latestPrice":46.88,"timestamp":1746734400000,"preClose":47.62,"halted":0,"volume":23404013,"hourTrading":{"tag":"盘后","latestPrice":46.89,"preClose":46.88,"latestTime":"19:59 EDT","volume":1675195,"amount":78553266.4485,"timestamp":1746748749285},"delay":0,"floatShares":2031143132,"shares":2035080810,"eps":2.670473,"marketStatus":"未开盘","change":-0.74,"latestTime":"05-08 16:00:00 EDT","open":47,"high":47.395,"low":46.52,"amount":1100319309.70369,"amplitude":0.018375,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.670473,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746777600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":-18475200000,"exchange":"NYSE","adjPreClose":47.62,"dividendRate":0.052048,"preHourTrading":{"tag":"盘前","latestPrice":47.04,"preClose":47.62,"latestTime":"09:29 EDT","volume":853999,"amount":40655527.63394,"timestamp":1746710999067},"postHourTrading":{"tag":"盘后","latestPrice":46.89,"preClose":46.88,"latestTime":"19:59 EDT","volume":1675195,"amount":78553266.4485,"timestamp":1746748749285},"volumeRatio":1.4969302776514017,"optionData":{"bulkOrders":[{"symbol":"BMY","call":false,"expireDate":1747368000000,"strike":"55.0","timestamp":1746732873207,"price":8.05,"volume":3910,"amount":3147550,"type":"+"},{"symbol":"BMY","call":false,"expireDate":1747368000000,"strike":"57.5","timestamp":1746732873207,"price":10.55,"volume":3910,"amount":4125050,"type":"+"}]},"impliedVol":0.3891,"impliedVolPercentile":0.8996},"requestUrl":"/m/hq/s/BMY","defaultTab":"news","newsList":[{"id":"2533591496","title":"百时美施贵宝药厂拟斥400亿美元拓展美国业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2533591496","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533591496?lang=zh_cn&edition=full","pubTime":"2025-05-06 09:21","pubTimestamp":1746494489,"startTime":"0","endTime":"0","summary":"格隆汇5月6日｜美国药厂百时美施贵宝(Bristol-Myers Squibb)准备未来5年，投放400亿美元在美国发展业务。公司首席执行官Christopher Boerner称，有关投资包括加速研发新药品，提升科技水平，以及设立美国厂房生产等项目。不过，Boerner未提及这笔投资是新增的，抑或已公布计划的总额。周一较早时，美国总统特朗普签署行政命令，指示相关部门精简药厂在美国设厂生产所须的审批流程，以推动本地药品生产。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050609214394ed58e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050609214394ed58e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1670710661.SGD","LU1571399168.USD","LU0225771236.USD","LU0321505868.SGD","LU0096364046.USD","LU1093756168.USD","LU1868836914.USD","LU1261432733.SGD","BK4581","LU0114720955.EUR","LU2242652126.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU1074936037.SGD","LU1032466523.USD","IE0002141913.USD","LU1291159041.SGD","BMY","LU1868836757.USD","LU0225284248.USD","LU2242646821.SGD","LU1670711040.USD","BK4559","LU0868494617.USD","LU0882574055.USD","LU0061475181.USD","LU1670711123.USD","LU1718418525.SGD","BK4534","LU1430594728.SGD","LU0456855351.SGD","LU0321505439.SGD","BK4585","IE0009355771.USD","LU1868836591.USD","LU1868837300.USD","BK4007","LU1323610961.USD","LU2133065610.SGD","LU1585245621.USD","LU1093756325.SGD","LU2125154778.USD","BK4532","LU0306807586.USD","LU0985481810.HKD","IE00BSNM7G36.USD","LU2360032135.SGD","LU1670710588.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2532008115","title":"施贵宝盘中异动 快速下挫3.01%报48.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532008115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532008115?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:34","pubTimestamp":1746106485,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时34分，施贵宝股票出现异动，股价快速下挫3.01%。截至发稿，该股报48.69美元/股，成交量83.7425万股，换手率0.04%，振幅2.06%。施贵宝股票所在的制药行业中，整体跌幅为4.10%。百时美施贵宝的一个重点是免疫肿瘤学，该公司在药物开发方面处于领先地位。百时美施贵宝近70%的总销售额来自美国，显示出对美国市场的依赖程度高于大多数同行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213445974c974b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213445974c974b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1430594728.SGD","BK4588","LU1868836591.USD","LU1868836914.USD","IE00BJJMRZ35.SGD","LU0321505439.SGD","LU1868836757.USD","IE0009355771.USD","LU1868837136.USD","LU1670710588.SGD","LU1032466523.USD","LU1291159041.SGD","LU1074936037.SGD","LU1261432733.SGD","IE00BJT1NW94.SGD","BMY","LU0237698245.USD","BK4534","LU1093756325.SGD","LU1670710661.SGD","BK4007","LU0868494617.USD","LU2125154778.USD","LU0456855351.SGD","LU1093756168.USD","IE00BFTCPJ56.SGD","LU2125154935.USD","LU1585245621.USD","LU1670711123.USD","IE00BSNM7G36.USD","LU0061475181.USD","LU1718418525.SGD","IE00BFXG1179.USD","LU1868837300.USD","LU2133065610.SGD","BK4532","BK4559","LU0306807586.USD","LU0114720955.EUR","IE00B2B36J28.USD","LU0985481810.HKD","LU1670711040.USD","LU1323610961.USD","LU2242646821.SGD","BK4581","LU0096364046.USD","LU0882574055.USD","BK4585","LU2360032135.SGD","LU0225771236.USD"],"gpt_icon":0},{"id":"1133351274","title":"高盛：美股医药股Q1业绩令人欣慰，行业情绪略微趋于积极","url":"https://stock-news.laohu8.com/highlight/detail?id=1133351274","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133351274?lang=zh_cn&edition=full","pubTime":"2025-04-28 17:44","pubTimestamp":1745833489,"startTime":"0","endTime":"0","summary":"在某些情况下甚至优于预期。","market":"us","thumbnail":"https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/content/detail/1286394.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BMY","JNJ","MRK"],"gpt_icon":1},{"id":"2530145445","title":"施贵宝2025财年第一财季实现净利润24.56亿美元，同比增加120.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530145445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530145445?lang=zh_cn&edition=full","pubTime":"2025-04-26 15:00","pubTimestamp":1745650847,"startTime":"0","endTime":"0","summary":"4月26日，施贵宝公布财报，公告显示公司2025财年第一财季净利润为24.56亿美元，同比增加120.62%；其中营业收入为112.01亿美元，同比减少5.60%，每股基本收益为1.21美元。机构评级：截至2025年4月26日，当前有19家机构对施贵宝目标价做出预测，其中目标均价为56.79美元，其中最低目标价为36.00美元，最高目标价为68.00美元。百时美施贵宝的一个重点是免疫肿瘤学，该公司在药物开发方面处于领先地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426150053a467cf42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426150053a467cf42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMY"],"gpt_icon":0},{"id":"2530925679","title":"摩根大通：将百时美施贵宝公司目标股价从70美元下调至67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530925679","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530925679?lang=zh_cn&edition=full","pubTime":"2025-04-25 12:35","pubTimestamp":1745555728,"startTime":"0","endTime":"0","summary":"摩根大通 ：将 百时美施贵宝 公司（BMY.N）目标股价从70美元下调至67美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425131307a4665213&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425131307a4665213&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","LU1989771016.USD","LU0225284248.USD","LU1670711123.USD","LU0096364046.USD","LU1670710588.SGD","LU1261432733.SGD","LU1868836757.USD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","LU1585245621.USD","LU2125154935.USD","IE00B2B36J28.USD","LU1032466523.USD","LU0456855351.SGD","LU0882574055.USD","LU1093756168.USD","BK4007","LU0225771236.USD","LU2242652126.USD","LU2133065610.SGD","LU1074936037.SGD","BK4559","LU0985481810.HKD","IE00BJJMRZ35.SGD","LU1718418525.SGD","LU1868837300.USD","IE0002141913.USD","BMY","LU0306807586.USD","LU0868494617.USD","BK4534","LU1868836591.USD","BK4585","LU0306806265.USD","LU0321505439.SGD","LU0237698245.USD","IE00BFXG1179.USD","LU1291159041.SGD","LU1670711040.USD","LU0114720955.EUR","IE0009355771.USD","LU1571399168.USD","LU2360032135.SGD","LU1430594728.SGD","LU1868836914.USD","BK4581","LU1670710661.SGD","LU1093756325.SGD","BK4532"],"gpt_icon":0},{"id":"1191442659","title":"施贵宝一季度营收、EPS超预期，提高全年营收及收益展望","url":"https://stock-news.laohu8.com/highlight/detail?id=1191442659","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191442659?lang=zh_cn&edition=full","pubTime":"2025-04-24 19:09","pubTimestamp":1745492990,"startTime":"0","endTime":"0","summary":"预计全年调整后每股收益6.70美元至7美元。","market":"us","thumbnail":"https://static.tigerbbs.com/a5217b0a313ff81f15acc1159bf44835","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5217b0a313ff81f15acc1159bf44835"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"施贵宝一季度营收、EPS超预期，提高全年营收及收益展望","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"gpt_icon":0},{"id":"2529614983","title":"百时美施贵宝公司提高2025全年调整后每股收益预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2529614983","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529614983?lang=zh_cn&edition=full","pubTime":"2025-04-24 19:06","pubTimestamp":1745492796,"startTime":"0","endTime":"0","summary":"格隆汇4月24日｜百时美施贵宝公司全年预计调整后每股收益6.70美元至7美元，此前预计6.55美元至6.85美元；预计营收大约458亿美元至468亿美元，此前预计大约455亿美元；仍然预测经调整毛利率大约72％，预估72.1％。第一季度业绩调整后每股收益1.80美元，上年同期每股亏损4.40美元，预估1.50美元；营收112.0亿美元，同比减少5.6%，预估107.5亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042419063994e0e968&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042419063994e0e968&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1868836757.USD","LU0061475181.USD","LU0306807586.USD","BK4585","LU1585245621.USD","LU2242646821.SGD","LU2360032135.SGD","LU1571399168.USD","IE00B2B36J28.USD","LU0321505868.SGD","LU0985481810.HKD","LU1323610961.USD","LU1670711040.USD","LU0096364046.USD","LU2125154778.USD","LU0456855351.SGD","LU0882574055.USD","BK4588","BMY","LU1093756168.USD","LU0868494617.USD","LU0114720955.EUR","LU1074936037.SGD","LU1868836914.USD","LU2133065610.SGD","LU1868837136.USD","BK4581","LU1032466523.USD","LU0237698245.USD","IE0002141913.USD","LU0225771236.USD","IE00BFTCPJ56.SGD","LU0306806265.USD","LU1670710588.SGD","BK4007","IE00BJJMRZ35.SGD","BK4534","LU2242652126.USD","IE00BSNM7G36.USD","IE0009355771.USD","LU1093756325.SGD","LU0321505439.SGD","LU1718418525.SGD","LU1868837300.USD","LU1670710661.SGD","IE00BFXG1179.USD","IE00BJT1NW94.SGD","LU1868836591.USD","LU0225284248.USD","LU1989771016.USD"],"gpt_icon":0},{"id":"2529253615","title":"Bristol-Myers Squibb(BMY.US)获Piper Sandler首次覆盖，给予增持评级, 目标价65.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529253615","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529253615?lang=zh_cn&edition=full","pubTime":"2025-04-22 23:53","pubTimestamp":1745337238,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb(BMY.US)获Piper Sandler首次覆盖，给予增持评级, 目标价65.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/22235349770938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BMY"],"gpt_icon":0},{"id":"2529312022","title":"百时美施贵宝（BMY.US）PD-1抑制剂在中国获批新适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2529312022","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529312022?lang=zh_cn&edition=full","pubTime":"2025-04-22 14:41","pubTimestamp":1745304064,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月22日，百时美施贵宝宣布，PD-1抑制剂欧狄沃获得中国NMPA批准新增适应症。此次获批后，纳武利尤单抗已在中国获批13项适应症，其中包括4项早期肿瘤适应症，包括围术期、新辅助和辅助治疗，覆盖肺癌、食管癌、尿路上皮癌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282149.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU2242646821.SGD","IE00B2B36J28.USD","LU1868836757.USD","BK4559","LU1989771016.USD","BK4588","LU0456855351.SGD","LU1032466523.USD","BK4534","IE00BJT1NW94.SGD","LU1670710588.SGD","BMY","LU1169590202.USD","LU0114720955.EUR","IE0009355771.USD","LU1868836591.USD","LU0321505439.SGD","LU0237698245.USD","BK4581","LU0225284248.USD","LU0985481810.HKD","LU1868836914.USD","IE0002141913.USD","LU1571399168.USD","LU0882574055.USD","LU1291159041.SGD","LU1718418525.SGD","IE00BSNM7G36.USD","IE00BFXG1179.USD","BK4585","LU2242652126.USD","LU2360032135.SGD","BK4532","LU1093756168.USD","LU1169589451.USD","IE00BJJMRZ35.SGD","LU2125154935.USD","LU1670711123.USD","LU1074936037.SGD","LU1261432733.SGD","LU0306807586.USD","LU1585245621.USD","LU0868494617.USD","LU0096364046.USD","LU1093756325.SGD","LU1323610961.USD","LU1430594728.SGD","LU0321505868.SGD","PD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2527423713","title":"施贵宝盘中异动 下午盘急速跳水3.00%报49.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527423713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527423713?lang=zh_cn&edition=full","pubTime":"2025-04-16 01:17","pubTimestamp":1744737424,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日01时17分，施贵宝股票出现波动，股价大幅跳水3.00%。截至发稿，该股报49.80美元/股，成交量707.248万股，换手率0.35%，振幅2.80%。施贵宝股票所在的制药行业中，整体跌幅为0.05%。百时美施贵宝的一个重点是免疫肿瘤学，该公司在药物开发方面处于领先地位。百时美施贵宝近70%的总销售额来自美国，显示出对美国市场的依赖程度高于大多数同行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416011704a459fcd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416011704a459fcd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1868837300.USD","LU1032466523.USD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","LU0096364046.USD","IE00B2B36J28.USD","LU1868836591.USD","LU1670710588.SGD","LU1261432733.SGD","IE00BJJMRZ35.SGD","IE00BFXG1179.USD","LU0061475181.USD","BMY","LU1093756325.SGD","LU0237698245.USD","IE0009355771.USD","LU0306806265.USD","LU1430594728.SGD","LU1585245621.USD","LU1093756168.USD","BK4585","LU1291159041.SGD","LU1868836757.USD","LU2125154935.USD","LU0225284248.USD","LU1868836914.USD","LU1868837136.USD","IE0002141913.USD","BK4559","BK4532","LU1323610961.USD","BK4588","LU0306807586.USD","LU0456855351.SGD","LU1571399168.USD","LU2242652126.USD","LU1989771016.USD","LU0321505439.SGD","BK4007","LU1074936037.SGD","LU1670711123.USD","LU0985481810.HKD","LU2133065610.SGD","LU0225771236.USD","LU0882574055.USD","LU2242646821.SGD","LU1718418525.SGD","LU0114720955.EUR","LU0868494617.USD"],"gpt_icon":0},{"id":"1159232209","title":"盘前异动 | CAR-T细胞疗法公司2Seventy涨近80%，获施贵宝溢价收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1159232209","media":"老虎资讯综合","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159232209?lang=zh_cn&edition=full","pubTime":"2025-03-11 19:04","pubTimestamp":1741691051,"startTime":"0","endTime":"0","summary":"本周二美股盘前时段，CAR-T细胞疗法公司 $2Seventy Bio Inc$ 暴涨近80%，截至发稿报 4.93 美元：消息面上，生物制药巨头 $施贵宝$ 将以每股 5 美元的现金价格收购 2seventy bio。百时美施贵宝和 2seventy bio 是基因疗法药物 Abecma 的合作伙伴，Abecma 已在美国获批用于治疗患有血癌多发性骨髓瘤的成年人。目前，2seventy bio管线中有多款CAR-T细胞疗法产品，其中Abecma由BMS合作开发和商业化，已在2021年获批上市。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"重磅收购！施贵宝79%溢价收购2Seventy Bio，CAR-T疗法领域再添新动力","news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSVT","BMY"],"gpt_icon":1},{"id":"2518120990","title":"施贵宝盘中异动 大幅拉升3.00%报62.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518120990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518120990?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:01","pubTimestamp":1741629691,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时01分，施贵宝股票出现波动，股价快速拉升3.00%。截至发稿，该股报62.92美元/股，成交量928.408万股，换手率0.46%，振幅3.59%。施贵宝股票所在的制药行业中，整体跌幅为1.93%。百时美施贵宝的一个重点是免疫肿瘤学，该公司在药物开发方面处于领先地位。百时美施贵宝近70%的总销售额来自美国，显示出对美国市场的依赖程度高于大多数同行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102013296406bba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102013296406bba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1571399168.USD","LU1670711123.USD","LU1670710588.SGD","LU0985481810.HKD","BK4581","LU0114720955.EUR","LU2133065610.SGD","IE00BFXG1179.USD","IE00BSNM7G36.USD","LU0096364046.USD","LU1032466523.USD","LU1093756325.SGD","LU2242652126.USD","LU1718418525.SGD","BK4534","IE00BFTCPJ56.SGD","LU1670711040.USD","LU0306807586.USD","LU1868836591.USD","LU0306806265.USD","LU0237698245.USD","LU0321505439.SGD","LU1291159041.SGD","BK4585","LU1074936037.SGD","LU1670710661.SGD","LU1868836914.USD","BK4559","IE00BJJMRZ35.SGD","LU0882574055.USD","IE00B2B36J28.USD","BK4532","LU0321505868.SGD","LU1093756168.USD","LU1868837300.USD","LU1989771016.USD","LU0868494617.USD","BMY","LU0061475181.USD","LU1585245621.USD","LU2125154935.USD","LU1323610961.USD","LU2242646821.SGD","LU0456855351.SGD","IE00BJT1NW94.SGD","LU0225284248.USD","BK4007","IE0009355771.USD","BK4588","LU2125154778.USD"],"gpt_icon":0},{"id":"2518292362","title":"金十数据整理：每日美股市场要闻速递（3月10日 周一）","url":"https://stock-news.laohu8.com/highlight/detail?id=2518292362","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518292362?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:02","pubTimestamp":1741611723,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1282649067.USD","LU1989772840.SGD","LU1720051017.SGD","09866","LU2357125470.USD","BK4007","NIO","LU2271345857.HKD","LU1551013425.SGD","BABA","LU0820562030.AUD","BK4602","XPEV","BK4527","LU2023251221.USD","LU1712237335.SGD","BRCD","EVS.SI","03145","TWmain","EWT","LU2023250504.SGD","LU1435385759.SGD","BK4532","LU1066051811.HKD","LU1868838027.USD","09988","PFE","TSYW.SI","TSM","BK4535","NIO.SI","TSLA","BMY","09868","BK4591","IE00BKVL7J92.USD","IE00BFXG0V08.USD","IE00BWXC8680.SGD","LU2326559502.SGD","LU2294711713.HKD","TSLL","LU1267930813.SGD","NVO","IE00BJJMRZ35.SGD","LU0882747503.HKD","BK6125","LU1868837300.USD","LU1242518931.SGD","LU0823411888.USD"],"gpt_icon":0},{"id":"2518226327","title":"王文涛部长会见百时美施贵宝董事会主席兼首席执行官博科思","url":"https://stock-news.laohu8.com/highlight/detail?id=2518226327","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518226327?lang=zh_cn&edition=full","pubTime":"2025-03-10 20:39","pubTimestamp":1741610361,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1430594728.SGD","LU2242652126.USD","LU0306806265.USD","IE00BFXG1179.USD","LU0456855351.SGD","LU1989771016.USD","LU2133065610.SGD","BK0188","LU1670710661.SGD","LU0225771236.USD","LU0306807586.USD","YINN","LU0321505439.SGD","IE0009355771.USD","LU1261432733.SGD","LU0237698245.USD","LU1093756168.USD","BK0250","LU1074936037.SGD","BRCD","IE00BJT1NW94.SGD","LU1032466523.USD","LU0985481810.HKD","BK4588","LU0114720955.EUR","LU1670711123.USD","BK4007","LU1718418525.SGD","IE00B2B36J28.USD","LU0868494617.USD","LU0061475181.USD","LU0225284248.USD","LU1571399168.USD","600056","BK4581","BMY","BK4532","IE00BJJMRZ35.SGD","LU1868836757.USD","LU1868836914.USD","IE0002141913.USD","LU2242646821.SGD","LU1868837136.USD","BK0185","BK4534","BK0010","BK0028","IE00BSNM7G36.USD","BK0175","BK0082"],"gpt_icon":0},{"id":"2518206204","title":"延长肝癌患者生命！百时美施贵宝(BMY.US)一线免疫组合疗法获欧盟批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2518206204","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518206204?lang=zh_cn&edition=full","pubTime":"2025-03-09 07:50","pubTimestamp":1741477805,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百时美施贵宝宣布，欧盟委员会已批准其重磅PD-1抑制剂Opdivo与CTLA-4靶向抗体Yervoy联用，一线治疗不可切除或晚期肝细胞癌成人患者。据悉，美国FDA已接受Opdivo联合Yervoy治疗同一患者群体的补充生物制品许可申请，预计在今年4月21日之前完成审评。公开资料显示，Opdivo是一种PD-1免疫检查点抑制剂，旨在帮助恢复抗肿瘤免疫反应，利用人体自身的免疫系统来对抗癌症。数据显示，Opdivo联合Yervoy治疗显著延长患者的总生存期，达到试验的主要临床终点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"延长肝癌患者生命！百时美施贵宝(BMY.US)一线免疫组合疗法获欧盟批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BFTCPJ56.SGD","LU1989771016.USD","LU0225284248.USD","LU0096364046.USD","LU1670710588.SGD","LU1261432733.SGD","LU1868836757.USD","LU2242646821.SGD","IE00BSNM7G36.USD","LU1585245621.USD","LU2125154935.USD","IE00B2B36J28.USD","LU1032466523.USD","LU0456855351.SGD","LU0882574055.USD","BK4588","LU1093756168.USD","BK4007","LU0225771236.USD","LU0321505868.SGD","LU2242652126.USD","LU2133065610.SGD","LU1074936037.SGD","BK4559","LU1868837300.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","BMY","LU0306807586.USD","LU0868494617.USD","LU1868836591.USD","LU1323610961.USD","BK4585","LU0306806265.USD","LU0321505439.SGD","LU0061475181.USD","LU0237698245.USD","IE00BFXG1179.USD","LU1291159041.SGD","LU1670711040.USD","LU0114720955.EUR","LU1571399168.USD","LU2360032135.SGD","LU1430594728.SGD","LU1868836914.USD","BK4581","LU1670710661.SGD","LU1093756325.SGD","BK4532","LU1868837136.USD"],"gpt_icon":0},{"id":"2517431600","title":"施贵宝(BMY)涨近3% 公司一款肝癌疗法获欧盟批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2517431600","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517431600?lang=zh_cn&edition=full","pubTime":"2025-03-07 22:59","pubTimestamp":1741359598,"startTime":"0","endTime":"0","summary":"金吾财讯 | 制药巨头百时美施贵宝（Bristol Myers Squibb，BMY）股价走高，截至发稿，涨2.97%，报61.97美元，成交额1.08亿美元。施贵宝宣布其开发的一款肝癌疗法已获得欧盟委员会批准。该公司称，其Opdivo和Yervoy联合疗法作为成年晚期肝癌患者的一线治疗方案，特别针对不可切除或晚期肝细胞癌，已获欧盟批准，这标志着欧盟及其相关国家在该类型癌症治疗选择方面取得重大进展。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/MzZmY2I0ODMyNDljNDZhYjk1YmMwYzA2ZTYzZmI3NWMyMTczNjIzMDYxMjY4Mg==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MzZmY2I0ODMyNDljNDZhYjk1YmMwYzA2ZTYzZmI3NWMyMTczNjIzMDYxMjY4Mg==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"286192","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096364046.USD","LU2242646821.SGD","LU1032466523.USD","LU1430594728.SGD","LU1291159041.SGD","LU0306807586.USD","LU1868836591.USD","LU1868836914.USD","LU1670710588.SGD","LU1093756168.USD","LU2242652126.USD","BK4534","LU0225284248.USD","LU1074936037.SGD","BK4532","LU0306806265.USD","LU1989771016.USD","BK4585","LU0985481810.HKD","LU0237698245.USD","LU0321505439.SGD","LU2133065610.SGD","IE00BFXG1179.USD","BK4007","LU0114720955.EUR","LU0321505868.SGD","LU0061475181.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU1868836757.USD","LU2125154778.USD","LU0456855351.SGD","BMY","BK4588","LU1868837300.USD","LU0882574055.USD","LU2360032135.SGD","LU0868494617.USD","IE0009355771.USD","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","LU1585245621.USD","LU2125154935.USD","IE0002141913.USD","LU1093756325.SGD","IE00BJT1NW94.SGD","LU1718418525.SGD","LU0225771236.USD","LU1261432733.SGD","LU1670710661.SGD"],"gpt_icon":0},{"id":"2517343196","title":"百时美施贵宝肝癌药物获得欧盟批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2517343196","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517343196?lang=zh_cn&edition=full","pubTime":"2025-03-07 22:52","pubTimestamp":1741359120,"startTime":"0","endTime":"0","summary":"制药巨头百时美施贵宝（Bristol Myers Squibb）宣布其开发的一款肝癌疗法已获得欧盟委员会批准。\n　　该公司称，其Opdivo和Yervoy联合疗法作为成年晚期肝癌患者的一线治疗方案，特别针对不可切除或晚期肝细胞癌，已获欧盟批准，这标志着欧盟及其相关国家在该类型癌症治疗选择方面取得重大进展。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-03-07/doc-inenwaua9553772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1430594728.SGD","BK4588","LU1868836591.USD","LU1868836914.USD","IE00BJJMRZ35.SGD","LU0321505439.SGD","IE0009355771.USD","LU1868837136.USD","LU0306806265.USD","LU1032466523.USD","LU1291159041.SGD","LU1670710588.SGD","LU1074936037.SGD","BMY","LU0237698245.USD","LU1093756325.SGD","LU1670710661.SGD","BK4007","LU0868494617.USD","LU2125154778.USD","LU0225284248.USD","LU0456855351.SGD","LU1093756168.USD","IE00BFTCPJ56.SGD","LU2125154935.USD","LU1585245621.USD","LU1670711123.USD","IE00BSNM7G36.USD","LU0061475181.USD","LU1718418525.SGD","IE00BFXG1179.USD","LU1868837300.USD","LU2133065610.SGD","BK4532","BK4559","LU0306807586.USD","LU0114720955.EUR","IE00B2B36J28.USD","LU0985481810.HKD","LU1670711040.USD","LU1323610961.USD","LU2242646821.SGD","BK4581","LU0096364046.USD","LU0321505868.SGD","IE0002141913.USD","LU0882574055.USD","BK4585","LU1989771016.USD","LU2360032135.SGD"],"gpt_icon":0},{"id":"2517124356","title":"弃了！百时美施贵宝终止KRAS G12D项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2517124356","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517124356?lang=zh_cn&edition=full","pubTime":"2025-03-07 13:16","pubTimestamp":1741324577,"startTime":"0","endTime":"0","summary":"2025年3月5日，据外媒消息， 百时美施贵宝 已放弃了此前收购的KRAS G12D抑制剂MRTX1133项目。寄予厚望的KRAS项目此前被百时美施贵宝看中的MRTX1133，就是一种有效的、选择性的和非共价的KRAS G12D抑制剂，目前处于I期临床阶段。试验数据“泼冷水”此次，放弃KRAS G12D抑制剂MRTX1133研发项目。这些负面消息让BMS对同为KRAS靶点的G12D项目未来的市场竞争力和商业前景深感担忧。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307132834abec709a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307132834abec709a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0096364046.USD","LU1868836914.USD","LU0868494617.USD","LU0061475181.USD","BK4585","LU0225771236.USD","LU1093756325.SGD","LU1261432733.SGD","LU1670711123.USD","LU1670710661.SGD","LU2133065610.SGD","LU0882574055.USD","LU1868836757.USD","BK4559","LU0321505868.SGD","LU2125154778.USD","LU0985481810.HKD","LU1291159041.SGD","LU1430594728.SGD","LU1571399168.USD","LU2125154935.USD","IE00BJT1NW94.SGD","LU1670710588.SGD","LU1670711040.USD","BK4007","BK4532","LU1989771016.USD","IE0002141913.USD","IE00BSNM7G36.USD","IE00B2B36J28.USD","LU1868837300.USD","LU0114720955.EUR","LU2242646821.SGD","BK4588","LU0456855351.SGD","IE00BFTCPJ56.SGD","BK4581","LU1074936037.SGD","LU1868836591.USD","LU0237698245.USD","BMY","IE00BJJMRZ35.SGD","LU0321505439.SGD","LU1868837136.USD","BK4534","LU0306807586.USD","IE0009355771.USD","LU1032466523.USD","LU0225284248.USD","LU1585245621.USD"],"gpt_icon":0},{"id":"2517979336","title":"市场动荡，3支防御性股票技术上稳固","url":"https://stock-news.laohu8.com/highlight/detail?id=2517979336","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517979336?lang=zh_cn&edition=full","pubTime":"2025-03-06 08:13","pubTimestamp":1741219980,"startTime":"0","endTime":"0","summary":"本文将重点介绍三只具有共同特征的股票：它们来自在熊市阶段表现较好的防御性行业，其股息收益率高于S&P 500，并且技术形态具有吸引力。BTI在1月中旬跳空上涨，创下52周新高，并在上月突破42美元，但在季度财报公布后出现跳空回落。财报不及预期使BTI股价下跌约13%，回落至50日移动均线，而该均线再次发挥关键支撑作用。当前，AEP站上两条上升趋势的移动均线，价格动能增强，相对强势提高，且股息收益率约为3.4%。","market":"hk","thumbnail":"http://imgcloud.jrjimg.cn/2025/03/weixin/one_20250306081320258.webp","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2025/03/weixin/one_20250306081320258.webp"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/03/06081348552984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0306806265.USD",".SPX","LU1093756168.USD","BMY","SDS","LU1032466523.USD","LU2360032135.SGD","VOO","LU0456855351.SGD","LU2125154935.USD","ESmain","BK4581","SH","BTI","LU0321505868.SGD","LU1093756325.SGD","LU1585245621.USD","IVV","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","SPY","BK4585","LU0868494617.USD","LU1894683348.USD","LU0061475181.USD","LU1718418525.SGD","LU1868836591.USD","BK4075","IE0009355771.USD","BK4081","LU0985481810.HKD","LU1291159041.SGD","LU2242652126.USD","BK4606","IE00B7SZLL34.SGD","BK4559","LU1074936037.SGD","LU1670710588.SGD","LU0882574055.USD","LU1868837136.USD","LU1989771016.USD","OEF","UPRO","LU0306807586.USD","IE00BSNM7G36.USD","LU2125154778.USD","OEX","SPXU","SSO","AEP"],"gpt_icon":0},{"id":"2514018286","title":"施贵宝盘中异动 股价大涨3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514018286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514018286?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:48","pubTimestamp":1740494939,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时48分，施贵宝股票出现波动，股价急速拉升3.01%。截至发稿，该股报59.62美元/股，成交量135.128万股，换手率0.07%，振幅2.26%。施贵宝股票所在的制药行业中，整体涨幅为2.03%。百时美施贵宝的一个重点是免疫肿瘤学，该公司在药物开发方面处于领先地位。百时美施贵宝近70%的总销售额来自美国，显示出对美国市场的依赖程度高于大多数同行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224859962ff6b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224859962ff6b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0321505439.SGD","LU1291159041.SGD","LU2360032135.SGD","BK4532","LU1670711040.USD","LU0114720955.EUR","LU1989771016.USD","IE00BJT1NW94.SGD","LU1074936037.SGD","LU1093756325.SGD","LU1868837136.USD","LU1868836914.USD","LU1571399168.USD","LU1670711123.USD","LU2133065610.SGD","LU0321505868.SGD","LU1093756168.USD","BK4559","LU2242646821.SGD","BK4007","LU1868836757.USD","LU1670710588.SGD","LU1670710661.SGD","LU1261432733.SGD","LU1868837300.USD","LU0882574055.USD","BK4534","LU2125154778.USD","BK4585","BMY","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0306806265.USD","LU2242652126.USD","LU0456855351.SGD","IE0009355771.USD","LU2125154935.USD","LU1868836591.USD","LU1323610961.USD","LU1430594728.SGD","LU0985481810.HKD","LU0868494617.USD","IE0002141913.USD","LU1032466523.USD","IE00BSNM7G36.USD","LU1585245621.USD","LU1718418525.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bms.com","stockEarnings":[{"period":"1week","weight":-0.055},{"period":"1month","weight":-0.1166},{"period":"3month","weight":-0.1754},{"period":"6month","weight":-0.1341},{"period":"1year","weight":0.0735},{"period":"ytd","weight":-0.1711}],"compareEarnings":[{"period":"1week","weight":0.0118},{"period":"1month","weight":0.1381},{"period":"3month","weight":-0.0594},{"period":"6month","weight":-0.0554},{"period":"1year","weight":0.0926},{"period":"ytd","weight":-0.0359}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"百时美施贵宝公司于1933年8月根据特拉华州法律注册成立，名为百时美公司，继承了1887年在纽约成立的一家企业。1989年，由于合并，公司更名为百时美施贵宝公司。该公司在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。该公司预计，对Celgene和MyoKardia的收购将进一步将公司定位为领先的生物制药公司，通过几项近期资产和额外的外部合作伙伴关系扩大其肿瘤学、血液学、免疫学和心血管领域的投资组合。","yearOnYearQuotes":[{"month":1,"riseRate":0.466667,"avgChangeRate":-0.012031},{"month":2,"riseRate":0.555556,"avgChangeRate":0.009164},{"month":3,"riseRate":0.644444,"avgChangeRate":0.008753},{"month":4,"riseRate":0.478261,"avgChangeRate":-0.005913},{"month":5,"riseRate":0.565217,"avgChangeRate":0.00204},{"month":6,"riseRate":0.622222,"avgChangeRate":0.010543},{"month":7,"riseRate":0.422222,"avgChangeRate":-0.000341},{"month":8,"riseRate":0.511111,"avgChangeRate":-0.003031},{"month":9,"riseRate":0.533333,"avgChangeRate":0.011131},{"month":10,"riseRate":0.577778,"avgChangeRate":0.025202},{"month":11,"riseRate":0.622222,"avgChangeRate":0.021304},{"month":12,"riseRate":0.622222,"avgChangeRate":0.020619}],"exchange":"NYSE","name":"施贵宝","nameEN":"Bristol-Myers Squibb"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"施贵宝,BMY,施贵宝股票,施贵宝股票老虎,施贵宝股票老虎国际,施贵宝行情,施贵宝股票行情,施贵宝股价,施贵宝股市,施贵宝股票价格,施贵宝股票交易,施贵宝股票购买,施贵宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}